CAH icon

Cardinal Health

137.34 USD
-0.43
0.31%
Updated Apr 1, 3:27 PM EDT
1 day
-0.31%
5 days
3.08%
1 month
6.32%
3 months
16.37%
6 months
24.48%
Year to date
16.37%
1 year
22.56%
5 years
187.86%
10 years
54.58%
 

About: Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Employees: 48,000

0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

107% more first-time investments, than exits

New positions opened: 172 | Existing positions closed: 83

24% more call options, than puts

Call options by funds: $281M | Put options by funds: $227M

22% more funds holding in top 10

Funds holding in top 10: 9 [Q3] → 11 (+2) [Q4]

7% more funds holding

Funds holding: 1,000 [Q3] → 1,073 (+73) [Q4]

6% more capital invested

Capital invested by funds: $23.3B [Q3] → $24.8B (+$1.5B) [Q4]

1% less repeat investments, than reductions

Existing positions increased: 370 | Existing positions reduced: 372

1.18% less ownership

Funds ownership: 87.17% [Q3] → 85.99% (-1.18%) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$129
6%
downside
Avg. target
$142
4%
upside
High target
$150
9%
upside

9 analyst ratings

positive
67%
neutral
33%
negative
0%
Mizuho
Steven Valiquette
29% 1-year accuracy
2 / 7 met price target
9%upside
$150
Outperform
Maintained
31 Mar 2025
Jefferies
Brian Tanquilut
44% 1-year accuracy
4 / 9 met price target
9%upside
$150
Buy
Upgraded
5 Feb 2025
JP Morgan
Lisa Gill
74% 1-year accuracy
17 / 23 met price target
6%upside
$145
Neutral
Maintained
4 Feb 2025
Wells Fargo
Stephen Baxter
32% 1-year accuracy
12 / 37 met price target
1%downside
$136
Equal-Weight
Maintained
4 Feb 2025
Morgan Stanley
Erin Wright
56% 1-year accuracy
14 / 25 met price target
3%upside
$142
Overweight
Maintained
31 Jan 2025

Financial journalist opinion

Based on 15 articles about CAH published over the past 30 days

Positive
Seeking Alpha
23 hours ago
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Best Dividend Aristocrats For April 2025
Negative
Zacks Investment Research
4 days ago
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Positive
Zacks Investment Research
5 days ago
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Neutral
Zacks Investment Research
5 days ago
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Here we discuss five non-tech stocks that have provided double-digit returns year to date, defying the negative trends of U.S. stock markets. These are TPR, WEC, CNP, CME and CEH.
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Negative
Zacks Investment Research
5 days ago
CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?
Cardinal Health's recent acquisitions and GMPD recovery look promising. However, the loss of the Optum Rx contract and margin pressure are likely to hurt short-term prospects.
CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?
Neutral
Zacks Investment Research
5 days ago
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
Cardinal Health (CAH) closed at $133.98 in the latest trading session, marking a +0.93% move from the prior day.
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
Positive
Zacks Investment Research
6 days ago
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
6 days ago
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Neutral
Zacks Investment Research
6 days ago
Cardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to Note
Cardinal Health (CAH) concluded the recent trading session at $132.75, signifying a -0.35% move from its prior day's close.
Cardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to Note
Neutral
PRNewsWire
1 week ago
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
Charts implemented using Lightweight Charts™